MTOR and neoplasm: Among seven potential tumor-suppressing miRNAs identified in this study, high expression of miR-100 was associated with better outcomes in women with luminal A tumors treated with adjuvant endocrine therapy and was inversely linked to mRNA expression of PLK1, FOXA1, mTOR, and IGF1R [44].